Showing 1161-1170 of 1206 results for "".
- Managing Employees During the COVID Pandemic: Answers to Top Questionshttps://modernaesthetics.com/news/managing-employees-in-the-covid-pandemic-answers-to-top-questions/2473040/Can I require staff to get a vaccine in order to continue working? In many cases, vaccines can be required, says Josh Alloy, JD, Counsel at Arnold and Porter in Washington, DC, “although there are potential e
- Aesthetics Biomedical Inaugurates Microneedling Dayhttps://modernaesthetics.com/news/aesthetics-biomedical-inaugurates-microneedling-day/2473008/It’s official! #NationalMicroneedlingDay is October 26. Aesthetics Biomedical® (ABM) says the day has been recognized by the National Day Archives as an official holiday on the National Day Registry™ to honor the leading radiofrequency microneedling treatment in th
- Cynosure Taps Vet Dr. Rafael Sierra for R&D Positionhttps://modernaesthetics.com/news/cynosure-taps-vet-rafael-sierra-phd-for-rd-position/2472992/Rafael Sierra, PhD is back at Cynosure. The former Chief Technology Officer is now an R&D Advisor. "Dr. Sierra's passion for the science behind medical aesthetics and inherent knowledge of its clinical application are unparalleled," says Todd
- RealSelf Medical Advisory Board Adds Plastic Surgeon Dr. Arian Mowlavihttps://modernaesthetics.com/news/realself-medical-advisory-board-adds-newport-beach-plastic-surgeon-dr-arian-mowlavi/2472947/Newport Beach, Calif.-based plastic surgeon Arian Mowlavi, MD is now a member of RealSelf’s Medical Advisory Board. “RealSelf is a leader in plastic surgery patient education and I am proud to a member of their Medical Advisory Board,” says Dr. Mowlavi of Cosmetic Plas
- ISPA Consumer Survey: Med Spas May Need a Post-COVID-19 Facelift to Ease Consumer Concernshttps://modernaesthetics.com/news/ispa-consumer-survey-medspas-may-need-a-post-covid-19-facelift-to-ease-consumer-concerns/2472923/Everyone is feeling anxious about returning to public spaces including spas following the COVID-19 pandemic, according to the new ISPA Consumer Snapshot Initiative. “We know that COVID-19 has created a lot of uncertainty in many industries, including the spa industry,” says
- COVID-19 By the Numbers: April 28 Editionhttps://modernaesthetics.com/news/covid-19-by-the-numbers-april-28-edition-1/2472920/The CDC now lists nine potential symptoms of COVID-19, though cough and shortness of breath or difficulty breathing remain hallmarks of the disease. CDC says individuals may have COVID-19 if they experience these two symptoms plus at least two of the following: Fever
- Survey Explores Negative Impact of COVID-9, Economic Fallout on Jobshttps://modernaesthetics.com/news/survey-explores-negative-impact-of-covid-9-economic-fallout-on-jobs/2472899/While 35 percent of 1,000 Americans surveyed by LendEDU say that that their jobs have not been impacted by the Coronavirus, six percent report losing their job, 13 percent report that hours have been partially cut, and 11 percent have had hours cut entirely, though they still have their jobs.
- Crown Laboratories Restructures after Acquisitionshttps://modernaesthetics.com/news/crown-laboratories-restructures-after-acquisitions/2472866/Crown Laboratories has restructured its commercial operations business units as it continues to elevate its new “Skin Science for Life” commitment. For the past two years, Crown says it has been dedicated to transforming its Northeast Tennessee operations into a global skinc
- Soliton RAP Update: First Patients Treated in Cellulite Trialhttps://modernaesthetics.com/news/soliton-rap-update-first-patients-treated-in-cellulite-trial/2471872/The first patients in Soliton’s cellulite trial have been treated, the Company reports. "Patient treatments have now begun at the Chicago site,” says Dr. Chris Capelli, President, CEO and co-founder of
- Cutera Launches excel V+ the Next Generation Laser Platformhttps://modernaesthetics.com/news/cutera-launches-excel-v-the-next-generation-laser-platform/2471949/Cutera, Inc. has launched its excel V+ laser platform, which the company describes as a technological advancement that includes 50 percent more power and treatment speed, optimized delivery systems and parameters for treating vascular lesions and pigmentation concerns. The company says th